Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Tapio Visakorpi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Physiology

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Waltering Kati K; Helenius Merja A; Sahu Biswajyoti; Manni Visa; Linja Marika J; Jänne Olli A; Visakorpi Tapio
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Laurila Marita; Tammela Teuvo L J; Auvinen Anssi; Isola Jorma; Visakorpi Tapio; Luukkaala Tiina; Määttänen Liisa; Ruutu Mirja; Ala-Opas Martti; Mildh Markus; Martikainen Paula
Biological aggressiveness of prostate cancer in the Finnish screening trial.
Jalava Sanni E; Porkka Kati P; Rauhala Hanna E; Isotalo Jarkko; Tammela Teuvo L; Visakorpi Tapio
TCEB1 promotes invasion of prostate cancer cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Tapio Visakorpi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Waltering Kati K; Helenius Merja A; Sahu Biswajyoti; Manni Visa; Linja Marika J; Jänne Olli A; Visakorpi Tapio
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Cancer research 2009;69(20):8141-9.
2009: Laurila Marita; Tammela Teuvo L J; Auvinen Anssi; Isola Jorma; Visakorpi Tapio; Luukkaala Tiina; Määttänen Liisa; Ruutu Mirja; Ala-Opas Martti; Mildh Markus; Martikainen Paula
Biological aggressiveness of prostate cancer in the Finnish screening trial.
International journal of cancer. Journal international du cancer 2009;124(3):547-52.
2009: Jalava Sanni E; Porkka Kati P; Rauhala Hanna E; Isotalo Jarkko; Tammela Teuvo L; Visakorpi Tapio
TCEB1 promotes invasion of prostate cancer cells.
International journal of cancer. Journal international du cancer 2009;124(1):95-102.
2009: Saramäki Outi R; Waltering Kati K; Visakorpi Tapio
Methods for identifying and studying genetic alterations in hormone-dependent cancers.
Methods in molecular biology (Clifton, N.J.) 2009;505():263-77.
2008: Ylösmäki Erkko; Hakkarainen Tanja; Hemminki Akseli; Visakorpi Tapio; Andino Raul; Saksela Kalle
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.
Journal of virology 2008;82(22):11009-15.
2008: Rauhala Hanna E; Porkka Kati P; Saramäki Outi R; Tammela Teuvo L J; Visakorpi Tapio
Clusterin is epigenetically regulated in prostate cancer.
International journal of cancer. Journal international du cancer 2008;123(7):1601-9.
2008: Murtola Teemu J; Visakorpi Tapio; Lahtela Jorma; Syvälä Heimo; Tammela Teuvo Lj
Statins and prostate cancer prevention: where we are now, and future directions.
Nature clinical practice. Urology 2008;5(7):376-87.
2008: Saramäki Outi R; Harjula Anna E; Martikainen Paula M; Vessella Robert L; Tammela Teuvo L J; Visakorpi Tapio
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3395-400.
2008: Abdulghani Junaid; Gu Lei; Dagvadorj Ayush; Lutz Jacqueline; Leiby Benjamin; Bonuccelli Gloria; Lisanti Michael P; Zellweger Tobias; Alanen Kalle; Mirtti Tuomas; Visakorpi Tapio; Bubendorf Lukas; Nevalainen Marja T
Stat3 promotes metastatic progression of prostate cancer.
The American journal of pathology 2008;172(6):1717-28.
2008: Laitinen Sari; Martikainen Paula M; Tolonen Teemu; Isola Jorma; Tammela Teuvo L J; Visakorpi Tapio
EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
International journal of cancer. Journal international du cancer 2008;122(3):595-602.
2008: Tan Shyh-Han; Dagvadorj Ayush; Shen Feng; Gu Lei; Liao Zhiyong; Abdulghani Junaid; Zhang Ying; Gelmann Edward P; Zellweger Tobias; Culig Zoran; Visakorpi Tapio; Bubendorf Lukas; Kirken Robert A; Karras James; Nevalainen Marja T
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
Cancer research 2008;68(1):236-48.
2008: Alhopuro Pia; Karhu Auli; Winqvist Robert; Waltering Kati; Visakorpi Tapio; Aaltonen Lauri A
Somatic mutation analysis of MYH11 in breast and prostate cancer.
BMC cancer 2008;8():263.
2008: Urbanucci Alfonso; Waltering Kati K; Suikki Hanna E; Helenius Merja A; Visakorpi Tapio
Androgen regulation of the androgen receptor coregulators.
BMC cancer 2008;8():219.
2007: Laitinen Sari; Martikainen Paula M; Tammela Teuvo L J; Visakorpi Tapio
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
European urology 2007;52(3):725-32.
2007: Mäki H E; Saramäki O R; Shatkina L; Martikainen P M; Tammela T L J; van Weerden W M; Vessella R L; Cato A C B; Visakorpi T
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
The Journal of pathology 2007;212(4):395-401.
2007: Porkka Kati P; Pfeiffer Minja J; Waltering Kati K; Vessella Robert L; Tammela Teuvo L J; Visakorpi Tapio
MicroRNA expression profiling in prostate cancer.
Cancer research 2007;67(13):6130-5.
2007: Dagvadorj Ayush; Collins Sean; Jomain Jean-Baptiste; Abdulghani Junaid; Karras James; Zellweger Tobias; Li Hongzhen; Nurmi Martti; Alanen Kalle; Mirtti Tuomas; Visakorpi Tapio; Bubendorf Lukas; Goffin Vincent; Nevalainen Marja T
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Endocrinology 2007;148(7):3089-101.
2007: Scott Clare L; Gil Jésus; Hernando Eva; Teruya-Feldstein Julie; Narita Masako; Martínez Dolores; Visakorpi Tapio; Mu David; Cordon-Cardo Carlos; Peters Gordon; Beach David; Lowe Scott W
Role of the chromobox protein CBX7 in lymphomagenesis.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(13):5389-94.
2007: Georgitsi M; Karhu A; Winqvist R; Visakorpi T; Waltering K; Vahteristo P; Launonen V; Aaltonen L A
Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.
British journal of cancer 2007;96(2):352-6.
2007: Visakorpi Tapio
[Not Available]
Duodecim; lääketieteellinen aikakauskirja 2007;123(11):1323-8.
2007: Saramaki Outi; Visakorpi Tapio
Chromosomal aberrations in prostate cancer.
Frontiers in bioscience : a journal and virtual library 2007;12():3287-301.
2006: Waltering Kati K; Wallén Mika J; Tammela Teuvo L J; Vessella Robert L; Visakorpi Tapio
Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
The Prostate 2006;66(15):1585-91.
2006: Mäki Hanna E; Waltering Kati K; Wallén Mika J; Martikainen Paula M; Tammela Teuvo L J; van Weerden Wytske M; Vessella Robert L; Visakorpi Tapio
Screening of genetic and expression alterations of SRC1 gene in prostate cancer.
The Prostate 2006;66(13):1391-8.
2006: Saramäki Outi R; Porkka Kati P; Vessella Robert L; Visakorpi Tapio
Genetic aberrations in prostate cancer by microarray analysis.
International journal of cancer. Journal international du cancer 2006;119(6):1322-9.
2006: Savinainen Kimmo J; Helenius Merja A; Lehtonen Heli J; Visakorpi Tapio
Overexpression of EIF3S3 promotes cancer cell growth.
The Prostate 2006;66(11):1144-50.
2006: Saramäki Outi R; Tammela Teuvo L J; Martikainen Paula M; Vessella Robert L; Visakorpi Tapio
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
Genes, chromosomes & cancer 2006;45(7):639-45.
2006: Helenius Merja A; Savinainen Kimmo J; Bova G Steven; Visakorpi Tapio
Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.
BJU international 2006;97(2):404-9.
2005: Sihto Harri; Puputti Marjut; Pulli Laura; Tynninen Olli; Koskinen Walter; Aaltonen Leena-Maija; Tanner Minna; Böhling Tom; Visakorpi Tapio; Bützow Ralf; Knuuttila Aija; Nupponen Nina N; Joensuu Heikki
Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.
Journal of molecular medicine (Berlin, Germany) 2005;83(12):976-83.
2005: Rauhala Hanna E; Porkka Kati P; Tolonen Teemu T; Martikainen Paula M; Tammela Teuvo L J; Visakorpi Tapio
Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
International journal of cancer. Journal international du cancer 2005;117(5):738-45.
2005: Marques Rute B; Erkens-Schulze Sigrun; de Ridder Corrina M; Hermans Karin G; Waltering Kati; Visakorpi Tapio; Trapman Jan; Romijn Johannes C; van Weerden Wytske M; Jenster Guido
Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
International journal of cancer. Journal international du cancer 2005;117(2):221-9.
2005: Karenko Leena; Hahtola Sonja; Päivinen Suvi; Karhu Ritva; Syrjä Sanna; Kähkönen Marketta; Nedoszytko Boguslaw; Kytölä Soili; Zhou Ying; Blazevic Vesna; Pesonen Maria; Nevala Hanna; Nupponen Nina; Sihto Harri; Krebs Inge; Poustka Annemarie; Roszkiewicz Jadwiga; Saksela Kalle; Peterson Pärt; Visakorpi Tapio; Ranki Annamari
Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
Cancer research 2005;65(18):8101-10.
2005: Bernard David; Martinez-Leal Juan F; Rizzo Sian; Martinez Dolores; Hudson David; Visakorpi Tapio; Peters Gordon; Carnero Amancio; Beach David; Gil Jesus
CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.
Oncogene 2005;24(36):5543-51.
2005: Wallén Mika; Tomás Eija; Visakorpi Tapio; Holli Kaija; Mäenpää Johanna
Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.
Cancer chemotherapy and pharmacology 2005;55(4):343-6.
2004: Linja Marika J; Visakorpi Tapio
Alterations of androgen receptor in prostate cancer.
The Journal of steroid biochemistry and molecular biology 2004;92(4):255-64.
2004: Porkka Kati P; Visakorpi Tapio
Molecular mechanisms of prostate cancer.
European urology 2004;45(6):683-91.
2004: Savinainen K J; Linja M J; Saramäki O R; Tammela T L J; Chang G T G; Brinkmann A O; Visakorpi T
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
British journal of cancer 2004;90(5):1041-6.
2004: Wang Ruoxiang; Xu Jianchun; Saramäki Outi; Visakorpi Tapio; Sutherland William M; Zhou Jianguang; Sen Buer; Lim So Dug; Mabjeesh Nicola; Amin Mahul; Dong Jin-Tang; Petros John A; Nelson Peter S; Marshall Fray F; Zhau Haiyen E; Chung Leland W K
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
Cancer research 2004;64(5):1589-94.
2004: Linja Marika J; Porkka Kati P; Kang Zhikang; Savinainen Kimmo J; Jänne Olli A; Tammela Teuvo L J; Vessella Robert L; Palvimo Jorma J; Visakorpi Tapio
Expression of androgen receptor coregulators in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1032-40.
2004: Nupponen Nina N; Wallén Mika J; Ponciano Damaris; Robbins Christiane M; Tammela Teuvo L J; Vessella Robert L; Carpten John D; Visakorpi Tapio
Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Genes, chromosomes & cancer 2004;39(2):119-25.
2004: Porkka Kati P; Tammela Teuvo L J; Vessella Robert L; Visakorpi Tapio
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Genes, chromosomes & cancer 2004;39(1):1-10.
2004: Vleugel Marije M; Bos Reinhard; Buerger Horst; van der Groep Petra; Saramäki Outi R; Visakorpi Tapio; van der Wall Elsken; van Diest Paul J
No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2004;26(5-6):347-51.
2003: Junttila Teemu T; Laato Matti; Vahlberg Tero; Söderström Karl-Ove; Visakorpi Tapio; Isola Jorma; Elenius Klaus
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5346-57.
2003: Visakorpi Tapio
The molecular genetics of prostate cancer.
Urology 2003;62(5 Suppl 1):3-10.
2003: Porkka Kati P; Nupponen Nina N; Tammela Teuvo L J; Vessella Robert L; Visakorpi Tapio
Human pHyde is not a classical tumor suppressor gene in prostate cancer.
International journal of cancer. Journal international du cancer 2003;106(5):729-35.
2003: Linja Marika J; Savinainen Kimmo J; Tammela Teuvo L J; Isola Jorma J; Visakorpi Tapio
Expression of ERalpha and ERbeta in prostate cancer.
The Prostate 2003;55(3):180-6.
2002: Porkka Kati P; Helenius Merja A; Visakorpi Tapio
Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.
Laboratory investigation; a journal of technical methods and pathology 2002;82(11):1573-82.
2002: Laitinen Sari; Karhu Ritva; Sawyers Charles L; Vessella Robert L; Visakorpi Tapio
Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
Genes, chromosomes & cancer 2002;35(1):66-73.
2002: Schulz Wolfgang A; Elo Jussi P; Florl Andrea R; Pennanen Sari; Santourlidis Simon; Engers Rainer; Buchardt Martin; Seifert Hans-Helge; Visakorpi Tapio
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.
Genes, chromosomes & cancer 2002;35(1):58-65.
2002: Kiuru Maija; Lehtonen Rainer; Arola Johanna; Salovaara Reijo; Järvinen Heikki; Aittomäki Kristiina; Sjöberg Jari; Visakorpi Tapio; Knuutila Sakari; Isola Jorma; Delahunt Brett; Herva Riitta; Launonen Virpi; Karhu Auli; Aaltonen Lauri A
Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
Cancer research 2002;62(16):4554-7.
2002: Joki-Erkkilä Minna M; Karikoski Riitta; Rantala Immo; Lenko Hanna-Liisa; Visakorpi Tapio; Heinonen Pentti K
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Journal of pediatric and adolescent gynecology 2002;15(3):145-9.
2002: Porkka Kati; Saramäki Outi; Tanner Minna; Visakorpi Tapio
Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.
Laboratory investigation; a journal of technical methods and pathology 2002;82(5):629-37.
2002: Leube Barbara; Drechsler Matthias; Mühlmann Kristina; Schäfer Reinhold; Schulz Wolfgang A; Santourlidis Simon; Anastasiadis Aristoteles; Ackermann Rolf; Visakorpi Tapio; Müller Wolfram; Royer-Pokora Brigitte
Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer.
The Prostate 2002;50(3):135-44.
2002: Savinainen Kimmo J; Saramäki Outi R; Linja Marika J; Bratt Ola; Tammela Teuvo L J; Isola Jorma J; Visakorpi Tapio
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
The American journal of pathology 2002;160(1):339-45.
2001: Saramäki O; Willi N; Bratt O; Gasser T C; Koivisto P; Nupponen N N; Bubendorf L; Visakorpi T
Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.
The American journal of pathology 2001;159(6):2089-94.
2001: Helenius M A; Saramäki O R; Linja M J; Tammela T L; Visakorpi T
Amplification of urokinase gene in prostate cancer.
Cancer research 2001;61(14):5340-4.
2001: Saramäki O R; Savinainen K J; Nupponen N N; Bratt O; Visakorpi T
Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer.
Cancer genetics and cytogenetics 2001;128(1):31-4.
2001: Isola J; Auvinen A; Poutiainen M; Kakkola L; Järvinen T A; Määttänen L; Stenman U H; Tammela T; Hakama M; Visakorpi T
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer.
The Journal of urology 2001;165(5):1569-74.
2001: Linja M J; Savinainen K J; Saramäki O R; Tammela T L; Vessella R L; Visakorpi T
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Cancer research 2001;61(9):3550-5.
2001: Elo J P; Visakorpi T
Molecular genetics of prostate cancer.
Annals of medicine 2001;33(2):130-41.
2001: Pan Y; Lui W O; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim U S; Kytölä S
5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
Genes, chromosomes & cancer 2001;30(2):187-95.
2001: Porkka K P; Visakorpi T
Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array.
The Journal of pathology 2001;193(1):73-9.
2000: Palmberg C; Koivisto P; Kakkola L; Tammela T L; Kallioniemi O P; Visakorpi T
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
The Journal of urology 2000;164(6):1992-5.
2000: Hernes E H; Linja M; Fosså S D; Visakorpi T; Berner A; Winderen M; Koivisto P A
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.
BJU international 2000;86(3):240-7.
2000: Nupponen N N; Isola J; Visakorpi T
Mapping the amplification of EIF3S3 in breast and prostate cancer.
Genes, chromosomes & cancer 2000;28(2):203-10.
1999: Wallén M J; Linja M; Kaartinen K; Schleutker J; Visakorpi T
Androgen receptor gene mutations in hormone-refractory prostate cancer.
The Journal of pathology 1999;189(4):559-63.
1999: Palmberg C; Koivisto P; Visakorpi T; Tammela T L
PSA decline is an independent prognostic marker in hormonally treated prostate cancer.
European urology 1999;36(3):191-6.
1999: Nupponen N N; Porkka K; Kakkola L; Tanner M; Persson K; Borg A; Isola J; Visakorpi T
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.
The American journal of pathology 1999;154(6):1777-83.
1999: Pan Y; Kytölä S; Farnebo F; Wang N; Lui W O; Nupponen N; Isola J; Visakorpi T; Bergerheim U S; Larsson C
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Cytogenetics and cell genetics 1999;87(3-4):225-32.
1999: Nupponen N N; Visakorpi T
Assignment of the protein kinase homolog of YAK1 (HIPK3) to human chromosome band 11p13 by in situ hybridization.
Cytogenetics and cell genetics 1999;87(1-2):102-3.
1999: Nupponen N; Visakorpi T
Molecular biology of progression of prostate cancer.
European urology 1999;35(5-6):351-4.
1999: Visakorpi T
Molecular genetics of prostate cancer.
Annales chirurgiae et gynaecologiae 1999;88(1):11-6.
1998: Nupponen N N; Kakkola L; Koivisto P; Visakorpi T
Genetic alterations in hormone-refractory recurrent prostate carcinomas.
The American journal of pathology 1998;153(1):141-8.
1998: Nupponen N N; Hyytinen E R; Kallioniemi A H; Visakorpi T
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization.
Cancer genetics and cytogenetics 1998;101(1):53-7.
1998: Koivisto P; Kolmer M; Visakorpi T; Kallioniemi O P
Androgen receptor gene and hormonal therapy failure of prostate cancer.
The American journal of pathology 1998;152(1):1-9.
1997: Koivisto P; Visakorpi T; Rantala I; Isola J
Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer.
The Journal of pathology 1997;183(1):51-6.
1997: Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Visakorpi T; Isola J
Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.
Genes, chromosomes & cancer 1997;18(2):94-101.
1997: Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi O P
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Cancer research 1997;57(2):314-9.
1997: Palmberg C; Koivisto P; Hyytinen E; Isola J; Visakorpi T; Kallioniemi O P; Tammela T
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
European urology 1997;31(2):216-9.
1997: Hyytinen E R; Thalmann G N; Zhau H E; Karhu R; Kallioniemi O P; Chung L W; Visakorpi T
Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
British journal of cancer 1997;75(2):190-5.
1996: Hakama M; Holli K; Visakorpi T; Pekola M; Kallioniemi O P
Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis.
International journal of cancer. Journal international du cancer 1996;66(1):6-10.
1996: Vuorinen V; Sallinen P; Haapasalo H; Visakorpi T; Kallio M; Jääskeläinen J
Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices.
Acta neurochirurgica 1996;138(12):1399-408.
1996: Koivisto P; Visakorpi T; Kallioniemi O P
Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1996;226():57-63.
1995: Koivisto P; Hyytinen E; Palmberg C; Tammela T; Visakorpi T; Isola J; Kallioniemi O P
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.
The American journal of pathology 1995;147(6):1608-14.
1995: Visakorpi T; Hyytinen E; Koivisto P; Tanner M; Keinänen R; Palmberg C; Palotie A; Tammela T; Isola J; Kallioniemi O P
In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
Nature genetics 1995;9(4):401-6.
1995: Hakama M; Holli K; Isola J; Kallioniemi O P; Kärkkäinen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J
Aggressiveness of screen-detected breast cancers.
Lancet 1995;345(8944):221-4.
1995: Visakorpi T; Kallioniemi A H; Syvänen A C; Hyytinen E R; Karhu R; Tammela T; Isola J J; Kallioniemi O P
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Cancer research 1995;55(2):342-7.
1995: Visakorpi T; Holli K; Hakama M
High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(5):605-9.
1994: Sallinen P K; Haapasalo H K; Visakorpi T; Helén P T; Rantala I S; Isola J J; Helin H J
Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
The Journal of pathology 1994;174(4):275-82.
1994: Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi O P
Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
The American journal of pathology 1994;145(3):624-30.
1994: Kallioniemi O P; Visakorpi T; Holli K; Isola J J; Rabinovitch P S
Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.
Cytometry 1994;16(3):250-5.
1994: Hyytinen E; Visakorpi T; Kallioniemi A; Kallioniemi O P; Isola J J
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Cytometry 1994;16(2):93-9.
1994: Visakorpi T; Kylmälä T; Tainio H; Koivula T; Tammela T; Isola J
High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(1):129-30.
1993: Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi O P
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):36-43.
1993: Visakorpi T; Kallioniemi O P; Koivula T; Isola J
New prognostic factors in prostatic carcinoma.
European urology 1993;24(4):438-49.
1992: Visakorpi T; Kallioniemi O P; Koivula T; Harvey J; Isola J
Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(6):643-8.
1992: Visakorpi T
Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
The Journal of pathology 1992;168(1):7-13.
1992: Isola J; Visakorpi T; Holli K; Kallioniemi O P
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Journal of the National Cancer Institute 1992;84(14):1109-14.
1992: Visakorpi T; Kallioniemi O P; Heikkinen A; Koivula T; Isola J
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.
Journal of the National Cancer Institute 1992;84(11):883-7.
1991: Kallioniemi O P; Holli K; Visakorpi T; Koivula T; Helin H H; Isola J J
Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.
International journal of cancer. Journal international du cancer 1991;49(5):650-5.
1991: Hyöty M; Visakorpi T; Kallioniemi O P; Mattila J; Laippala P; Nordback I
Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
The European journal of surgery = Acta chirurgica 1991;157(10):595-600.
1991: Visakorpi T; Kallioniemi O P; Paronen I Y; Isola J J; Heikkinen A I; Koivula T A
Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.
British journal of cancer 1991;64(3):578-82.
1991: Kallioniemi O P; Visakorpi T; Holli K; Heikkinen A; Isola J; Koivula T
Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.
Cytometry 1991;12(5):413-21.
1991: Kallioniemi O P; Holli K; Visakorpi T; Koivula T; Helin H; Isola J
[New studies on breast cancer to predict disease outcome and clinical use of these new tests]
Duodecim; lääketieteellinen aikakauskirja 1991;107(11):907-16.
1987: Visakorpi T; Vilja P; Kulomaa M; Tuohimaa P; Klockars M
Cerebrospinal fluid lactoferrin in bacterial and viral meningitis.
Acta paediatrica Scandinavica 1987;76(6):987-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Tapio Visakorpi

Research Profile (preview)

Disorders

Procedures

Physiology

Chemicals & Drugs

Anatomy

Phenomena

Living Beings

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Tapio Visakorpi (preview)

All Publications